TerminatedPhase 4

Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency

Stopped: The trial was prematurely terminated due to low recruitment

Greece7 participantsStarted 2001-05-16

Plain-language summary

This trial is conducted in Europe. The aim of this trial is to investigate the effect of growth hormone on left ventricle morphology and function (systolic and diastolic).

Who can participate

Age range12 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult growth hormone deficiency * At least 2 years without growth hormone treatment Exclusion Criteria: * Supine blood pressure above 160 mmHg systolic or above 100 mmHg diastolic * Pregnancy

What they're measuring

Left Ventricular systolic function

Left Ventricular diastolic function

Trial details

NCT IDNCT01698944

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2002-11-18

View on ClinicalTrials.gov More Growth Hormone Disorder trials